Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 09-2015 | 09-2014 | 09-2013 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,008 | -316 | -23 | -226 | -1,070 |
| Depreciation Amortization | N/A | N/A | N/A | 24 | 33 |
| Accounts receivable | N/A | N/A | 1 | -1 | N/A |
| Accounts payable and accrued liabilities | 18 | N/A | N/A | N/A | N/A |
| Other Working Capital | 6,238 | 315 | 18 | 165 | 143 |
| Other Operating Activity | 1,277 | 0 | -1 | 1 | -21 |
| Operating Cash Flow | $-3,475 | $-1 | $-6 | $-38 | $-915 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | -65 | N/A | -19 |
| Other Investing Activity | 0 | 0 | -65 | 0 | -20 |
| Investing Cash Flow | $N/A | $N/A | $-65 | $N/A | $-20 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 7 | 25 | 221 |
| Common Stock Issued | 2,350 | 949 | N/A | N/A | N/A |
| Other Financing Activity | 303 | 47 | 64 | 0 | 655 |
| Financing Cash Flow | $2,653 | $996 | $71 | $25 | $876 |
| Beginning Cash Position | 995 | N/A | 1 | 13 | 72 |
| End Cash Position | 174 | 995 | 2 | 1 | 13 |
| Net Cash Flow | $-821 | $995 | $1 | $-13 | $-58 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,475 | -1 | -6 | -38 | -915 |
| Free Cash Flow | -3,475 | -1 | -6 | -38 | -915 |